These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 9796706)
1. Molecular analysis of two putative tumour suppressor genes, PTEN and DMBT, which have been implicated in glioblastoma multiforme disease progression. Somerville RP; Shoshan Y; Eng C; Barnett G; Miller D; Cowell JK Oncogene; 1998 Oct; 17(13):1755-7. PubMed ID: 9796706 [TBL] [Abstract][Full Text] [Related]
2. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052 [TBL] [Abstract][Full Text] [Related]
3. PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas. Chiariello E; Roz L; Albarosa R; Magnani I; Finocchiaro G Oncogene; 1998 Jan; 16(4):541-5. PubMed ID: 9484844 [TBL] [Abstract][Full Text] [Related]
4. Microsatellite deletion mapping on chromosome 10q and mutation analysis of MMAC1, FAS, and MXI1 in human glioblastoma multiforme. Fults D; Pedone CA; Thompson GE; Uchiyama CM; Gumpper KL; Iliev D; Vinson VL; Tavtigian SV; Perry WL Int J Oncol; 1998 Apr; 12(4):905-10. PubMed ID: 9499454 [TBL] [Abstract][Full Text] [Related]
6. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. Tohma Y; Gratas C; Biernat W; Peraud A; Fukuda M; Yonekawa Y; Kleihues P; Ohgaki H J Neuropathol Exp Neurol; 1998 Jul; 57(7):684-9. PubMed ID: 9690672 [TBL] [Abstract][Full Text] [Related]
7. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Liu W; James CD; Frederick L; Alderete BE; Jenkins RB Cancer Res; 1997 Dec; 57(23):5254-7. PubMed ID: 9393744 [TBL] [Abstract][Full Text] [Related]
8. PTEN mutations in gliomas and glioneuronal tumors. Duerr EM; Rollbrocker B; Hayashi Y; Peters N; Meyer-Puttlitz B; Louis DN; Schramm J; Wiestler OD; Parsons R; Eng C; von Deimling A Oncogene; 1998 Apr; 16(17):2259-64. PubMed ID: 9619835 [TBL] [Abstract][Full Text] [Related]
9. Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas. Maier D; Zhang Z; Taylor E; Hamou MF; Gratzl O; Van Meir EG; Scott RJ; Merlo A Oncogene; 1998 Jun; 16(25):3331-5. PubMed ID: 9681833 [TBL] [Abstract][Full Text] [Related]
10. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter. Fujisawa H; Kurrer M; Reis RM; Yonekawa Y; Kleihues P; Ohgaki H Am J Pathol; 1999 Aug; 155(2):387-94. PubMed ID: 10433932 [TBL] [Abstract][Full Text] [Related]
11. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Steck PA; Pershouse MA; Jasser SA; Yung WK; Lin H; Ligon AH; Langford LA; Baumgard ML; Hattier T; Davis T; Frye C; Hu R; Swedlund B; Teng DH; Tavtigian SV Nat Genet; 1997 Apr; 15(4):356-62. PubMed ID: 9090379 [TBL] [Abstract][Full Text] [Related]
12. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Teng DH; Hu R; Lin H; Davis T; Iliev D; Frye C; Swedlund B; Hansen KL; Vinson VL; Gumpper KL; Ellis L; El-Naggar A; Frazier M; Jasser S; Langford LA; Lee J; Mills GB; Pershouse MA; Pollack RE; Tornos C; Troncoso P; Yung WK; Fujii G; Berson A; Steck PA Cancer Res; 1997 Dec; 57(23):5221-5. PubMed ID: 9393738 [TBL] [Abstract][Full Text] [Related]
13. Somatic mutations of PTEN in glioblastoma multiforme. Wang SI; Puc J; Li J; Bruce JN; Cairns P; Sidransky D; Parsons R Cancer Res; 1997 Oct; 57(19):4183-6. PubMed ID: 9331071 [TBL] [Abstract][Full Text] [Related]
14. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766 [TBL] [Abstract][Full Text] [Related]
15. Inactivation of the PTEN/MMAC1/TEP1 gene in human lung cancers. Kohno T; Takahashi M; Manda R; Yokota J Genes Chromosomes Cancer; 1998 Jun; 22(2):152-6. PubMed ID: 9598803 [TBL] [Abstract][Full Text] [Related]
17. Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers. Cairns P; Evron E; Okami K; Halachmi N; Esteller M; Herman JG; Bose S; Wang SI; Parsons R; Sidransky D Oncogene; 1998 Jun; 16(24):3215-8. PubMed ID: 9671402 [TBL] [Abstract][Full Text] [Related]
18. Analysis of the PTEN gene in human meningiomas. Peters N; Wellenreuther R; Rollbrocker B; Hayashi Y; Meyer-Puttlitz B; Duerr EM; Lenartz D; Marsh DJ; Schramm J; Wiestler OD; Parsons R; Eng C; von Deimling A Neuropathol Appl Neurobiol; 1998 Feb; 24(1):3-8. PubMed ID: 9549723 [TBL] [Abstract][Full Text] [Related]
19. PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis. Sasaki H; Zlatescu MC; Betensky RA; Ino Y; Cairncross JG; Louis DN Am J Pathol; 2001 Jul; 159(1):359-67. PubMed ID: 11438483 [TBL] [Abstract][Full Text] [Related]
20. Analysis of loss of chromosome 10q, DMBT1 homozygous deletions, and PTEN mutations in oligodendrogliomas. Sanson M; Leuraud P; Aguirre-Cruz L; He J; Marie Y; Cartalat-Carel S; Mokhtari K; Duffau H; Delattre JY; Hoang-Xuan K J Neurosurg; 2002 Dec; 97(6):1397-401. PubMed ID: 12507139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]